FdaApplication
ANDA 210534
Identifiers
- fda_app_no: ANDA210534
Properties
| Property | Value |
|---|---|
| applicant_name | ALKEM LABORATORIES LTD |
| application_type | ANDA |
| approval_date | 2021-02-19 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CEFDINIR | CEFDINIR | 125MG/5ML | FOR SUSPENSION;ORAL |
| CEFDINIR | CEFDINIR | 250MG/5ML | FOR SUSPENSION;ORAL |
2 products